20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
The risk of coronavirus may be lower than the flu, but with the numbers of cases and fatalities grow...
Read More >
In the first two parts of this series on best practices in protecting trade secrets, we addressed ri...
Read More >
The U.S. Court of Appeals for the Eighth Circuit recently affirmed a district court’s issuance of a...
Read More >
Yesterday, Governor Newsom signed AB 1561 (Garcia/Greyson) extending most residential entitlements f...
Read More >
In March of this year, New York State issued restrictions on the operation of all businesses, provid...
Read More >
Employers may be surprised to learn that the Republican-controlled National Labor Relations Board ju...
Read More >